巨噬细胞炎性蛋白3β(MIP3b)活性蛋白

Active Macrophage Inflammatory Protein 3 Beta (MIP3b)

CCL19; CKb11; ELC; MIP3-B; SCYA19; Chemokine C-C-Motif Ligand 19; Beta Chemokine Exodus-3; CK Beta-11; EBI1-Ligand Chemokine; Small Inducible Cytokine Subfamily A19

  • 巨噬细胞炎性蛋白3β(MIP3b)活性蛋白 产品包装(模拟)
  • 巨噬细胞炎性蛋白3β(MIP3b)活性蛋白 产品包装(模拟)
  • APA096Hu01.png Figure. SDS-PAGE
  • 巨噬细胞炎性蛋白3β(MIP3b)活性蛋白 Sample: Recombinant MIP3b, Human;
    Antibody: Rabbit Anti-Human MIP3b Ab (PAA096Hu01)
    Figure. Western Blot
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

活性实验

Macrophage Inflammatory Protein 3 Beta (MIP3b) is a small cytokine belonging to the CC chemokine family that is also known as EBI1 ligand chemokine (ELC) and Chemokine C-C motif ligand 19 (CCL19). This chemokine elicits its effects on its target cells by binding to the chemokine receptor chemokine receptor CCR7. It attracts certain cells of the immune system, including dendritic cells and antigen-engaged B cells, CCR7 central-memory T-Cells. Thus, chemotaxis assay used 24-well microchemotaxis system was undertaken to detect the chemotactic effect of recombinant human MIP3b on the Jurkat cell line. Briefly, Jurkat cells were seeded into the upper chambers (150μL cell suspension,106 cells/mL in RPMI 1640 with FBS free) and MIP3b (0.01ng/mL, 0.1ng/mL, 1ng/mL, 10ng/mL, 100ng/mL and 1000ng/mL diluted separately in serum free RPMI 1640) was added in lower chamber with a polycarbonate filter (8μm pore size) used to separate the two compartments. After incubation at 37℃ with 5% CO2 for 3h, the filter was removed, then cells in low chamber were observed by inverted microscope at low magnification (×100) and the number of migrated cells were counted at high magnification (×400) randomly (five fields for each filter). Result shows MIP3b is able to induce migration of Jurkat cells. The migrated Jurkat cells in low chamber at low magnification (×100) were shown in Figure 1. Five fields of each chamber were randomly chosen, and the migrated cells were counted at high magnification (×400). Statistical results were shown in Figure 2. The optimum chemotaxis of recombinant human MIP3b occurs at 0.1-1ng/mL.
(A) Jurkat cells were seeded into the upper chambers and serum free RPMI 1640 with 0.1ng/mL MIP3b was added in lower chamber, then cells in lower chamber were observed at low magnification (×100) after incubation for 3h;
(B) Jurkat cells were seeded into the upper chambers and serum free RPMI 1640 without MIP3b was added in lower chamber, then cells in lower chamber were observed at low magnification (×100) after incubation for 3h.
Figure. The chemotactic effect of recombinant human MIP3b on Jurkat cells.

Figure. The chemotactic effect of recombinant human MIP3b on Jurkat cells.

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA096Hu01 巨噬细胞炎性蛋白3β(MIP3b)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA096Hu01 巨噬细胞炎性蛋白3β(MIP3b)活性蛋白 Cell culture; Activity Assays.
PAA096Hu01 巨噬细胞炎性蛋白3β(MIP3b)多克隆抗体 WB; IHC; ICC; IP.
LAA096Hu71 巨噬细胞炎性蛋白3β(MIP3b)多克隆抗体(生物素标记) WB; IHC; ICC.
MAA096Hu22 巨噬细胞炎性蛋白3β(MIP3b)单克隆抗体 WB; IHC; ICC; IP.
SEA096Hu 巨噬细胞炎性蛋白3β(MIP3b)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA096Hu 巨噬细胞炎性蛋白3β(MIP3b)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
BMC Veterinary Research MIP-3beta/CCL19 is associated with the intrathecal invasion of mononuclear cells in neuroinflammatory and non-neuroinflammatory CNS diseases in dogs [Pubmed:25016392]
Brain, Behavior, and Immunity Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model [Pubmed:25266150]
Brain, Behavior, and Immunity Plasma inflammatory biomarkers for Huntington’s disease patients and mouse model [PubMed: 25266150]
类风湿关节炎血清中CCL19 和CCL21 的表达水平与肺间质病变的关系 [:]
留言咨询